Antibodies to Signaling Molecules and Receptors in Alzheimer’s Disease are Associated with Psychomotor Slowing, Depression, and Poor Visuospatial Function

Author:

Giil Lasse M.12,Vedeler Christian A.34,Kristoffersen Einar K.25,Nordrehaug Jan Erik26,Heidecke Harald7,Dechend Ralf89,Schulze-Forster Kai7,Muller Dominik N.810,von Goetze Victoria S.7,Cabral-Marques Otavio11,Riemekasten Gabriela11,Vogelsang Petra15,Nygaard Staale12,Lund Anders2,Aarsland Dag1314

Affiliation:

1. Department of Internal Medicine, Haraldsplass Deaconess Hospital, Bergen, Norway

2. Department of Clinical Science, University of Bergen, Bergen, Norway

3. Department of Clinical Medicine, University of Bergen, Bergen, Norway

4. Department of Neurology, Haukeland University Hospital, Bergen, Norway

5. Department of Immunology and Transfusion Medicine, Haukeland University Hospital, Bergen, Norway

6. Department of Cardiology, Stavanger University Hospital, Stavanger, Norway

7. CellTrend GmbH, Luckenwalde, Berlin, Germany

8. Experimental and Clinical Research Center, Charité Medical Faculty and the Max-Delbruck Center for Molecular Medicine, Berlin, Germany

9. HELIOS-Klinikum Berlin, Berlin, Germany

10. Max-Delbruck Center for Molecular Medicine, Berlin, Germany

11. Department of Rheumatology, University Hospital Schleswig-Holstein, Lübeck, Germany

12. Research Group for Biomedical Informatics, University of Oslo, Oslo, Norway

13. Department of Old Age Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, Kings College, UK

14. Centre for Age-Related Diseases (SESAM), Stavanger University Hospital, Norway

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference60 articles.

1. The dementias;Ritchie;Lancet

2. Amyloid-β and tau — a toxic pas de deux in Alzheimer’s disease;Ittner;Nat Rev Neurosci,2011

3. Apoptosis in neurodegenerative disorders;Mattson;Nat Rev Mol Cell Biol,2000

4. Alzheimer’s disease is a synaptic failure;Selkoe;Science,2002

5. Alzheimer’s disease;Querfurth;NEngl J Med,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3